Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tonkin

Showing results (311-320 of 338) with videos related to

Pageof 34
Sort By:
Circulation|October 21, 2016
Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes MellitusZahir H Alshehry, Piyushkumar A Mundra, Christopher K Barlow, et al.
Clinical Trials (London, England)|July 6, 2025
From the ASPREE investigators: Response to Wittes et alJohn J McNeil, Andrew M Tonkin, Anne B Newman, et al.
JAMA|March 29, 2012
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysisS Matthijs Boekholdt, Benoit J Arsenault, Samia Mora, et al.
JAMA Cardiology|October 15, 2025
Clonal Hematopoiesis and Cardiovascular Disease and Bleeding Risk and the Effectiveness of AspirinZoe K McQuilten, Le T P Thao, Alexander G Bick, et al.
JCI Insight|July 12, 2019
Changes in plasma lipids predict pravastatin efficacy in secondary preventionKaushala S Jayawardana, Piyushkumar A Mundra, Corey Giles, et al.
Kidney International|September 13, 2020
Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney diseaseRory Wolfe, James B Wetmore, Robyn L Woods, et al.
Neurology|October 25, 2023
Association Between Triglycerides and Risk of Dementia in Community-Dwelling Older Adults: A Prospective Cohort StudyZhen Zhou, Joanne Ryan, Andrew M Tonkin, et al.
Circulation|August 23, 2013
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysisS Matthijs Boekholdt, Benoit J Arsenault, G Kees Hovingh, et al.
Eclinicalmedicine|January 26, 2026
Association between statin use and risk of incident cancer in healthy older adults: a target trial emulation using data from a multicentre, randomised trial of community-dwelling older adults in Australia and the USAGebiso Roba Debele, Najmeh Davoodian, Mojtaba Lotfaliany, et al.
Journal of Lipid Research|April 11, 2025
Statin effects on the lipidome: Predicting statin usage and implications for cardiovascular risk predictionChangyu Yi, Kevin Huynh, Yvette Schooneveldt, et al.
Pageof 34

Showing results (311-320 of 338) with videos related to

Sort By:
Pageof 34
Circulation|October 21, 2016
Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes MellitusZahir H Alshehry, Piyushkumar A Mundra, Christopher K Barlow, et al.
Clinical Trials (London, England)|July 6, 2025
From the ASPREE investigators: Response to Wittes et alJohn J McNeil, Andrew M Tonkin, Anne B Newman, et al.
JAMA|March 29, 2012
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysisS Matthijs Boekholdt, Benoit J Arsenault, Samia Mora, et al.
JAMA Cardiology|October 15, 2025
Clonal Hematopoiesis and Cardiovascular Disease and Bleeding Risk and the Effectiveness of AspirinZoe K McQuilten, Le T P Thao, Alexander G Bick, et al.
JCI Insight|July 12, 2019
Changes in plasma lipids predict pravastatin efficacy in secondary preventionKaushala S Jayawardana, Piyushkumar A Mundra, Corey Giles, et al.
Kidney International|September 13, 2020
Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney diseaseRory Wolfe, James B Wetmore, Robyn L Woods, et al.
Neurology|October 25, 2023
Association Between Triglycerides and Risk of Dementia in Community-Dwelling Older Adults: A Prospective Cohort StudyZhen Zhou, Joanne Ryan, Andrew M Tonkin, et al.
Circulation|August 23, 2013
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysisS Matthijs Boekholdt, Benoit J Arsenault, G Kees Hovingh, et al.
Eclinicalmedicine|January 26, 2026
Association between statin use and risk of incident cancer in healthy older adults: a target trial emulation using data from a multicentre, randomised trial of community-dwelling older adults in Australia and the USAGebiso Roba Debele, Najmeh Davoodian, Mojtaba Lotfaliany, et al.
Journal of Lipid Research|April 11, 2025
Statin effects on the lipidome: Predicting statin usage and implications for cardiovascular risk predictionChangyu Yi, Kevin Huynh, Yvette Schooneveldt, et al.
Pageof 34